Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Polysubstance abuse, using multiple types of drugs at the same time, is a common cause of death from overdose and an ...

Naloxone, the opioid overdose-reversing medication commonly known by its brand name Narcan, was central to the response of ...

None of the 27 people who overdosed on a suspected bad batch of drugs Thursday in Baltimore’s Penn North neighborhood have ...

CDSCO highlighted that improper disposal can lead to these substances being scavenged or misused, putting lives at risk. The ...

Researchers at the Medical University of South Carolina have made a breakthrough in pain management. They’ve found that ...

The unregulated drug supply is now composed of more and more ingredients, making it more difficult to respond, treat and ...

The South East Health Unit (SEHU) issued a news release on Tuesday noting a recent rise in drug-involved poisonings in the ...

The potent synthetic opioid, developed for large animals, threatens to reverse Michigan's recent progress in reducing ...

The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.